dronabinol has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roth, MD | 1 |
| Arnaud, C; Burger, F; Frossard, JL; Karsak, M; Mach, F; Pelli, G; Staub, C; Steffens, S; Veillard, NR; Zimmer, A | 1 |
2 other study(ies) available for dronabinol and Arteriosclerosis
| Article | Year |
|---|---|
Pharmacology: marijuana and your heart.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Chemotaxis, Leukocyte; Dronabinol; Humans; Inflammation; Macrophages; Mice; Receptor, Cannabinoid, CB2; Receptors, CCR2; Receptors, Chemokine | 2005 |
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.
Topics: Animals; Apolipoproteins E; Arteriosclerosis; Cells, Cultured; Chemotaxis, Leukocyte; Disease Models, Animal; Disease Progression; Dronabinol; Humans; Inflammation; Interferon-gamma; Macrophages; Mice; Mice, Knockout; Receptor, Cannabinoid, CB2; Receptors, CCR2; Receptors, Chemokine; RNA, Messenger; Survival Rate; Th1 Cells; Thioglycolates; Tumor Necrosis Factor-alpha | 2005 |